Nuwellis, Inc.

NUWE

Healthcare Medical Devices

Nuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024.

Revenue
+14.1%
EPS
+98.8%
Free cash flow
−51.6%

Quarter to June 2026, against a year earlier

4.58 0.08 −1.72%
Market cap
$2.5M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
3/9
ROIC
0.00%
Net debt / EBITDA
0.1×
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.35 0.15 0.25 0.06
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(0.91) (0.40) (0.70) (0.17)
P/B ratio
0.73 0.46 0.82 0.00
EV/Sales
0.45 0.49 0.46 0.06
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(0.39) (0.37) (0.35) (0.05)
Current Ratio
2.04 1.71 1.56 1.97
Net Debt/EBITDA
1.24 0.42 0.46 1.25
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(2,727.67%) (5,144.23%) (5,979.24%) (2,932.14%)
Free Cash Flow Yield
(330.15%) (906.97%) (531.18%) (2,297.98%)
Free Cash Flow per Share
(1,201.85) (1,371.82) (489.70) (158.41)
Book value per Share
1,447.41 1,195.45 404.39 (101.74)
Free Cash Flow
(3.24) (3.02) (3.23) (3.18)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026